Baby Collagen
Human-derived Type I/III collagen injection
About This Treatment
Baby Collagen is human-derived Type I/III collagen injectable for regeneration. Unlike bovine/porcine sources (conventional), human origin triggers minimal immune response with slow absorption. Post-injection fibroblast stimulation promotes endogenous collagen production—fundamental regenerative medicine. Rare allergies, very high safety.
Mechanism of Action
Injected human collagen directly binds to fibroblast integrins, activating new collagen production. Micro-trauma from injection triggers wound healing response. Slow absorption rate (30-50% slower than traditional) sustains fibroblast stimulation long-term. Over 3-6 months, endogenous collagen neogenesis improves skin thickness and firmness significantly.
Indications
Expected Results
Immediate volume, 3-6 months endogenous collagen neogenesis. 40-60% wrinkle improvement, 50% firmness increase. Results last 1+ year.
Clinical Evidence
Risks & Side Effects
Transient injection-site redness/swelling (1-3 days), minor bruising (1-2 weeks). Allergies very rare (<0.1%). Infection risk extremely low (no immune rejection with human source).
Interested in this treatment?
Start with an AI skin analysis to check your current skin condition